Busca avançada
Ano de início
Entree


Ruthenium(II)-mercapto complexes induce cell damage via apoptosis pathway on ovarian cancer cells

Texto completo
Autor(es):
Palmeira-Mello, Marcos, V ; Teixeira, Tamara ; de Melo, Matheus Reis Santos ; Nicolella, Heloiza Diniz ; Dutra, Jocely L. ; Cominetti, Marcia R. ; Rocha, Fillipe Vieira ; Tavares, Denise Crispim ; Batista, Alzir A.
Número total de Autores: 9
Tipo de documento: Artigo Científico
Fonte: Journal of Inorganic Biochemistry; v. 265, p. 10-pg., 2025-01-04.
Resumo

Ovarian cancer represents a leading cause of cancer-related deaths in women worldwide. Chemotherapeutic agents are usually employed to treat the patients, and Ruthenium(II)-based compounds have been investigated as possible substitutes for platinum drugs. In this work, we studied three different Ru(II)-phosphine-mercapto complexes (1-3) as potential cytotoxic agents against A2780 and A2780-cisR ovarian cancer cells. A time- dependent cytotoxicity was observed for 2 , which also exhibited better selectivity than cisplatin control. A similar cytotoxic behavior was observed on 3D tumor spheroids. Although no changes were observed in cell cycle distribution, compound 2 affected the mitochondrial membrane potential on A2780 cells, and caused cell death via apoptotic pathway, which was confirmed by flow cytometry assay. Western blotting experiments revealed that 2 affected the expression of p53, PCNA, gamma H2AX and cleaved caspase-3, making it a promising anticancer agent for ovarian cancer. (AU)

Processo FAPESP: 22/02876-0 - Avaliação do perfil biológico de complexos de coordenação: uma abordagem em modelos celulares 2D e 3D
Beneficiário:Fillipe Vieira Rocha
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 21/01787-0 - Estudo in vitro e in vivo de complexos fosfínicos de Ru(II) com atividades anticancerígenas
Beneficiário:Marcos Vinícius Palmeira de Mello
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 23/02475-8 - Complexos fosfínicos de Ru(II) com naftoquinonas e derivados: potenciais anticancerígenos, estudos in vitro e in vivo
Beneficiário:Alzir Azevedo Batista
Modalidade de apoio: Auxílio à Pesquisa - Regular